Summary
- Current Price
- As of today, ENGN price is $1.81, up +2.26% in the most recent trading session on
- Current Price All-Time High
- ENGN price is currently -96.16% below its historical high of $47.17 set on
- Market Cap
- ENGN current market cap is $121M, down -60.83% year-over-year
- Revenue
- ENGN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for ENGN is on
Profile
| Metric | Value |
|---|---|
| Full Name | enGene Therapeutics Inc. |
| Ticker | NASDAQ: ENGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | engene.com |
| Employees | 81 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $1.81 | |
| Price, 1D Change | +2.26% | |
| $121M | ||
| - | ||
| - | ||
| 2.15 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.29 | ||
| EPS, 1Y Change | -57.23% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.29 | ||
| EPS Estimate | -$1.73 | |
| EPS Est. Change | +24.74% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $1.81 | |
| Price Target | $4.00 | - |
| Price Tgt. Change | +120.99% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.39 | -$1.46 | -5.23% | |
| -$2.10 | -$2.29 | -9.16% | |
| -$1.73 | N/A | +24.74% | |
| -$1.40 | N/A | +38.78% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $6.17M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $1.81 | |
| $5.56 | ||
| $1.82 | ||
| $4.22 | ||
| $2.00 | ||
| $0.01 | ||
| 2.15 | ||
| $0.09 | ||
| 45.08 | ||
| 51.03% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.29 | ||
| -$509.00K | ||
| - | ||
| -$123.17M | ||
| - | ||
| -$117.30M | ||
| - | ||
| -$122.66M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.19 | ||
| 6.30 | ||
| 6.30 | ||
| - | ||
| - | ||
| -1.92 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 0.53 | ||
| 0.82 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $167.71M | ||
| $193.82M | ||
| $221.47M | ||
| $201.39M | ||
| $53.76M | ||
| $31.98M | ||
| $31.80M | ||
| $10.02M | ||
| $6.69M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $117.30M | ||
| $122.66M | ||
| $509.00K | ||
| $0.00 | ||
| $509.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$99.24M | ||
| -$25.14M | ||
| $1.52M | ||
| $1.49M | ||
| -$100.72M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| Wells Fargo | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Citizens | → | |
| WBB Securities | ||
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ENGN
FAQ
- What is the ticker symbol for enGene Therapeutics Inc.?
- The ticker symbol for enGene Therapeutics Inc. is NASDAQ:ENGN
- Does enGene Therapeutics Inc. pay dividends?
- No, enGene Therapeutics Inc. does not pay dividends
- What sector is enGene Therapeutics Inc. in?
- enGene Therapeutics Inc. is in the Healthcare sector
- What industry is enGene Therapeutics Inc. in?
- enGene Therapeutics Inc. is in the Biotechnology industry
- What country is enGene Therapeutics Inc. based in?
- enGene Therapeutics Inc. is headquartered in Canada
- When did enGene Therapeutics Inc. go public?
- enGene Therapeutics Inc. initial public offering (IPO) was on February 1, 2022
- Is enGene Therapeutics Inc. in the S&P 500?
- No, enGene Therapeutics Inc. is not included in the S&P 500 index
- Is enGene Therapeutics Inc. in the NASDAQ 100?
- No, enGene Therapeutics Inc. is not included in the NASDAQ 100 index
- Is enGene Therapeutics Inc. in the Dow Jones?
- No, enGene Therapeutics Inc. is not included in the Dow Jones index
- When was enGene Therapeutics Inc. last earnings report?
- enGene Therapeutics Inc.'s most recent earnings report was on September 8, 2026
- When does enGene Therapeutics Inc. report earnings?
- The next expected earnings date for enGene Therapeutics Inc. is January 4, 2027
Data Sources & References
- ENGN Official Website www.engene.com
- ENGN Profile on Yahoo Finance finance.yahoo.com/quote/ENGN
- ENGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/engn